Related Experiment Video

Updated: Jul 11, 2026

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
09:03

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Published on: November 23, 2014

Targeting integrin beta4 for cancer and anti-angiogenic therapy

Filippo G Giancotti1

  • 1Cell Biology Program, Sloan-Kettering Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 216, New York, NY 10021, USA. f-giancotti@ski.mskcc.org

Trends in Pharmacological Sciences
|September 8, 2007
PubMed

Insights

Integrin beta4 amplifies receptor tyrosine kinase signaling, driving cancer progression and angiogenesis. Blocking integrin beta4 and these kinases simultaneously offers a novel therapeutic strategy for cancer and anti-angiogenic therapy.

Area of Science:

  • Oncology
  • Cell Signaling
  • Molecular Biology

Background:

  • Integrins are crucial in pathological angiogenesis and tumor progression.
  • Integrin beta4 (a laminin receptor) is upregulated in tumor and endothelial cells.
  • Integrin beta4 enhances signaling of receptor tyrosine kinases like ErbB2, EGF-R, and Met.

Purpose of the Study:

  • To discuss the hypothesis that integrin beta4 promotes angiogenesis and tumorigenesis by amplifying receptor tyrosine kinase signaling.
  • To propose a combined therapeutic approach targeting integrin beta4 and receptor tyrosine kinases.

Main Methods:

  • Literature review and hypothesis formulation based on existing biochemical and genetic studies.
  • Discussion of signaling pathways involving integrin beta4 and receptor tyrosine kinases.

Main Results:

  • Integrin beta4 signaling is hypothesized to amplify receptor tyrosine kinase activity.
  • This amplification is proposed to drive both angiogenesis and tumorigenesis.

Conclusions:

  • Simultaneous blockade of integrin beta4 and receptor tyrosine kinases is a rational therapeutic strategy.
  • This approach holds promise for cancer therapy and anti-angiogenic treatment.

More Related Videos

Preparing a 68Ga-labeled Arginine Glycine Aspartate (RGD)-peptide for Angiogenesis07:48

Preparing a 68Ga-labeled Arginine Glycine Aspartate (RGD)-peptide for Angiogenesis

Published on: January 7, 2019

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...